THE National University of Singapore has awarded the `Research Excellence Award 2025` to the Dow Institute of Biological, Biochemical and Pharmaceutical Sciences, as per a press release, for its success in research aimed at reducing mortality rates related to antimicrobial resistance.

The study focuses on bloodstream infections and ventilator-associated pneumonia with hospital-acquired infection. Dow-IBBPS completed its global surveillance study, with 41 clinical trial active sites globally, in collaboration with the National University of Singapore. This study may bring new interventions in the future to reduce the mortality rate, which currently stands at almost 25 per cent per recent studies. •